DOSSIER · 13F Holders · Q2 2026
SAGE THERAPEUTICS CVR
4 institutions still hold SAGE THERAPEUTICS CVR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 786CVR019·4 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
4 institutions reported SAGE THERAPEUTICS CVR in Q2 2026. Top-holder concentration data is loading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.